ATE525396T1 - Slo2 und slo4, neue kaliumkanal-proteine aus menschlichem gehirn - Google Patents
Slo2 und slo4, neue kaliumkanal-proteine aus menschlichem gehirnInfo
- Publication number
- ATE525396T1 ATE525396T1 AT01964104T AT01964104T ATE525396T1 AT E525396 T1 ATE525396 T1 AT E525396T1 AT 01964104 T AT01964104 T AT 01964104T AT 01964104 T AT01964104 T AT 01964104T AT E525396 T1 ATE525396 T1 AT E525396T1
- Authority
- AT
- Austria
- Prior art keywords
- slo2
- potassium channel
- channel proteins
- slo4
- human brain
- Prior art date
Links
- 102000004257 Potassium Channel Human genes 0.000 title abstract 3
- 108020001213 potassium channel Proteins 0.000 title abstract 3
- 210000004556 brain Anatomy 0.000 title 1
- 239000003112 inhibitor Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000012216 screening Methods 0.000 abstract 2
- 108091082510 Slo family Proteins 0.000 abstract 1
- 102000003734 Voltage-Gated Potassium Channels Human genes 0.000 abstract 1
- 108090000013 Voltage-Gated Potassium Channels Proteins 0.000 abstract 1
- 239000012190 activator Substances 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000004036 potassium channel stimulating agent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24911200P | 2000-11-15 | 2000-11-15 | |
| US09/921,159 US7041494B2 (en) | 2000-11-15 | 2001-08-01 | DNA encoding Slo2 and Slo4, potassium channel |
| PCT/US2001/025701 WO2002040649A1 (en) | 2000-11-15 | 2001-08-15 | Slo2 and slo4, novel potassium channel proteins from human brain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE525396T1 true ATE525396T1 (de) | 2011-10-15 |
Family
ID=26939832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01964104T ATE525396T1 (de) | 2000-11-15 | 2001-08-15 | Slo2 und slo4, neue kaliumkanal-proteine aus menschlichem gehirn |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US7041494B2 (de) |
| EP (2) | EP1334178B1 (de) |
| JP (1) | JP2005507633A (de) |
| AT (1) | ATE525396T1 (de) |
| AU (2) | AU2001284995B2 (de) |
| CA (1) | CA2428350A1 (de) |
| WO (1) | WO2002040649A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003234914A1 (en) * | 2002-05-14 | 2003-11-11 | Takeda Pharmaceutical Company Limited | Novel proteins and dnas thereof |
| US20240116991A1 (en) * | 2021-02-08 | 2024-04-11 | Institut National de la Santé et de la Recherche Médicale | Bile salts bactosensor and use thereof for diagnositc and therapeutic purposes |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1112299A (en) * | 1997-10-22 | 1999-05-10 | Washington University | A ph sensitive potassium channel in spermatocytes |
| US20030143676A1 (en) * | 1999-03-25 | 2003-07-31 | Genesis Research And Development Corporation Limited | Fibroblast growth factor receptors and methods for their use |
| US6972187B2 (en) * | 2000-05-12 | 2005-12-06 | Millennium Pharmaceuticals, Inc. | OAT5 molecules and uses therefor |
| AU2001265009A1 (en) * | 2000-05-24 | 2001-12-03 | Curagen Corporation | Human polynucleotides and polypeptides encoded thereby |
| US20020048787A1 (en) * | 2000-06-14 | 2002-04-25 | Ming-Hui Wei | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| AU2001280981A1 (en) * | 2000-08-03 | 2002-02-18 | Incyte Genomics, Inc. | Transporters and ion channels |
| WO2003000842A2 (en) * | 2001-06-04 | 2003-01-03 | Curagen Corporation | Novel proteins and nucleic acids encoding same |
-
2001
- 2001-08-01 US US09/921,159 patent/US7041494B2/en not_active Expired - Fee Related
- 2001-08-15 EP EP01964104A patent/EP1334178B1/de not_active Expired - Lifetime
- 2001-08-15 EP EP10176436A patent/EP2295454A1/de not_active Withdrawn
- 2001-08-15 CA CA002428350A patent/CA2428350A1/en not_active Abandoned
- 2001-08-15 AT AT01964104T patent/ATE525396T1/de not_active IP Right Cessation
- 2001-08-15 WO PCT/US2001/025701 patent/WO2002040649A1/en not_active Ceased
- 2001-08-15 JP JP2002543646A patent/JP2005507633A/ja active Pending
- 2001-08-15 AU AU2001284995A patent/AU2001284995B2/en not_active Ceased
- 2001-08-15 AU AU8499501A patent/AU8499501A/xx active Pending
-
2006
- 2006-01-04 US US11/325,764 patent/US7411043B2/en not_active Expired - Fee Related
-
2008
- 2008-07-22 US US12/177,819 patent/US7767450B2/en not_active Expired - Fee Related
-
2010
- 2010-03-09 US US12/720,461 patent/US7893209B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP2295454A1 (de) | 2011-03-16 |
| JP2005507633A (ja) | 2005-03-24 |
| US20060099640A1 (en) | 2006-05-11 |
| EP1334178A4 (de) | 2006-03-29 |
| CA2428350A1 (en) | 2002-05-23 |
| US7767450B2 (en) | 2010-08-03 |
| WO2002040649A8 (en) | 2002-11-07 |
| US20090017534A1 (en) | 2009-01-15 |
| US20100267930A1 (en) | 2010-10-21 |
| US7893209B2 (en) | 2011-02-22 |
| AU2001284995B2 (en) | 2007-03-29 |
| AU8499501A (en) | 2002-05-27 |
| EP1334178A1 (de) | 2003-08-13 |
| EP1334178B1 (de) | 2011-09-21 |
| US20030017533A1 (en) | 2003-01-23 |
| WO2002040649A1 (en) | 2002-05-23 |
| US7411043B2 (en) | 2008-08-12 |
| US7041494B2 (en) | 2006-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60134136D1 (de) | Zytokinrezeptoruntereinheit-proteine aus säugetieren, damit zusammenhängende reagenzien und methoden | |
| DE69833014D1 (de) | Menschliche toll homologen | |
| MXPA02011656A (es) | Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos. | |
| AU2001294541A1 (en) | Mammalian genes; related reagents and methods | |
| NO2010021I2 (no) | Denosumab | |
| EP1490483A4 (de) | In-vivo-einbau von nicht in der natur vorkommenden aminosäuren | |
| EA200600042A1 (ru) | Способы образования дисульфидных связей и гликозилирования белков и реагенты, применяемые в этих способах | |
| DE60041697D1 (de) | Säugetier-rezeptorproteine; ähnliche reagentien und methoden | |
| DE69728897D1 (de) | Saeugetierchemokine | |
| EP1183330A4 (de) | Kv10.1, EIN NEUER POTENTIAL-ABHÄNGIGER KALIUMKANAL DES MENSCHLICHEN GEHIRNS | |
| WO2002026929A3 (en) | Kini-3 motor protein and methods for its use | |
| DE69328060D1 (de) | Angiotensin-II Typ-1 Rezeptor und dessen Herstellung | |
| ATE330011T1 (de) | Bevorzugte segmente des ntp-proteins (neural thread protein) und verfahren zu deren verwendung | |
| AU8499501A (en) | Slo2 and slo4, novel potassium channel proteins from human brain | |
| WO2001096593A3 (en) | Novel motor proteins and methods for their use | |
| WO2002012541A3 (en) | Novel motor proteins and methods for their use | |
| WO2002079479A3 (en) | Motor proteins and methods for their use | |
| WO2001087932A3 (en) | Seven transmembrane proteins and polynucleotides encoding the same | |
| WO2004053142A3 (en) | P53-associated parkin-like cytoplasmic protein, and related compositions and methods | |
| WO2003004678A3 (en) | Novel receptors | |
| WO2003012120A3 (en) | Lp354 mammalian secreted protein | |
| ATE397753T1 (de) | Screening-verfahren für eine prophylaktische und therapeutische substanz für eine nierenerkrankung | |
| WO2001098314A3 (en) | Novel motor proteins and methods for their use | |
| WO2003048320A3 (en) | Novel motor protein of p. falciparum and methods for its use | |
| WO2002016435A3 (en) | Human 7tm proteins and polynucleotides encoding the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |